Clinical Validation of AdvanSure GenoBlot Assay as Primary Screening and Test of Cure for Human Papillomavirus Infection

BACKGROUND: Clinical specificity and sensitivity are essential factors in the adoption of a human papillomavirus (HPV) test as a primary screening tool and test of cure after treatment of cervical cancer and precancerous lesions (High-Risk-Lesion). Using histologically-confirmed High-Risk-Lesion-pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kahng, Jimin, Oh, Eun-Jee, Lee, Hae Nam, Lee, Dae Woo, Kim, Yonggoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Laboratory Medicine 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948825/
https://www.ncbi.nlm.nih.gov/pubmed/24624348
http://dx.doi.org/10.3343/alm.2014.34.2.127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948825/
https://www.ncbi.nlm.nih.gov/pubmed/24624348
http://dx.doi.org/10.3343/alm.2014.34.2.127

Ejemplares similares